1. Home
  2. SIBN vs ESPR Comparison

SIBN vs ESPR Comparison

Compare SIBN & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$15.45

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.88

Market Cap

793.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIBN
ESPR
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
793.7M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
SIBN
ESPR
Price
$15.45
$2.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$25.00
$7.20
AVG Volume (30 Days)
494.3K
2.9M
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
41.33
86.21
EPS
N/A
N/A
Revenue
$67,301,000.00
$332,314,000.00
Revenue This Year
$16.71
$27.35
Revenue Next Year
$14.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.53
185.66
52 Week Low
$12.50
$0.73
52 Week High
$21.89
$4.18

Technical Indicators

Market Signals
Indicator
SIBN
ESPR
Relative Strength Index (RSI) 41.09 31.01
Support Level $14.75 $2.66
Resistance Level $15.98 $2.94
Average True Range (ATR) 0.69 0.16
MACD 0.13 -0.04
Stochastic Oscillator 30.99 4.09

Price Performance

Historical Comparison
SIBN
ESPR

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: